Hsp90 inhibitors: a potential treatment for latent EBV infection? - Wikidata - wikimedia - TriplyDB

Hsp90 inhibitors: a potential treatment for latent EBV infection?

Hsp90 inhibitors: a potential treatment for latent EBV infection?

http://www.wikidata.org/entity/Q40855750

about

p38 phosphorylates Rb on Ser567 by a novel, cell cycle-independent mechanism that triggers Rb-Hdm2 interaction and apoptosis Interactions between Hsp90 and oncogenic viruses: implications for viral cancer therapeutics HSP90: chaperone-me-not.Utilising proteomic approaches to understand oncogenic human herpesviruses (Review).HSP90: a promising broad-spectrum antiviral drug target.

P2860

Q24301099-30BCBBFC-374E-4C4A-9658-7CFD64D3818E Q35376259-DC8DAE15-4A9A-46B7-BAD8-60E5002FAA70 Q38125419-B731EB99-C93F-48E4-9547-F61C185D540B Q38256387-7A536842-FB5A-4595-AF99-958DFDDC0D19 Q40093256-60C8ECBB-8A14-4FE7-8C83-49BA384D0C16

P2860

Hsp90 inhibitors: a potential treatment for latent EBV infection?

http://www.wikidata.org/entity/Q40855750

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Hsp90 inhibitors: a potential treatment for latent EBV infection?

@en

type

label

Hsp90 inhibitors: a potential treatment for latent EBV infection?

@en

prefLabel

Hsp90 inhibitors: a potential treatment for latent EBV infection?

@en

P1433

Q40855750-2F1F4DF5-A2BD-4612-BE02-31DA4EA340FE

P1476

Q40855750-C0B6E4FB-7BBF-4D55-80C8-681F406A1655

P2093

Q40855750-67C637F4-DD5E-4B86-8950-6383256B89DA

Q40855750-6F1677B7-19AD-4530-AE81-25588FA202F8

P2860

Q40855750-0C42FEED-E21E-40BF-B2CD-6D51AF44E3D1

Q40855750-2297A62D-3839-473A-933A-3E62297AC925

Q40855750-3580BDCD-D545-40E4-9BC4-9249736303BE

Q40855750-43293243-8E18-4576-8734-83FE1A2B38E8

Q40855750-6084B8EB-5858-4327-AE42-F01EE0397A17

Q40855750-8EB282EC-9B32-4DB1-B127-3352E5D931DD

Q40855750-9CD27348-A460-4855-A15D-4BA622EF6B9B

Q40855750-A888EB64-D7AA-4BAE-96DA-03CED90592C8

Q40855750-C53A7F81-D233-48DD-97FA-54251EB56318

Q40855750-CF770319-0D10-4A30-97C4-7E9E9DD31BB6

P304

Q40855750-9073D7B6-1714-4168-AD0C-CA89E14A395E

P31

Q40855750-6FFE6504-B5F3-4492-A1A6-58BB77EDD1A5

Q40855750-885c41b8-8366-4c7a-a289-2d1b97d4f40e

P356

Q40855750-050A5FB4-F607-4DE7-BD26-CE3DBC62C711

P433

Q40855750-638A93BB-868C-4B00-9ADA-B0CA26357BEF

P478

Q40855750-3A01E85C-0156-476C-8269-BA94C07026E0

P577

Q40855750-D15A52A2-FFEF-4B23-95F5-367D9BF8BF22

P5875

Q40855750-4E246607-ECEB-4D88-A77B-2A67AE6EDB4D

P698

Q40855750-F2F40E61-C062-40D5-8FC8-90463F0163AC

P932

Q40855750-5718585A-7311-483D-AD23-A16BA4159724

P356

P1433

P1476

Hsp90 inhibitors: a potential treatment for latent EBV infection?

@en

P2093

Shannon C Kenney

http://www.w3.org/2001/XMLSchema#string

Xiaoping Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Interaction of Hsp90 with ribosomal proteins protects from ubiquitination and proteasome-dependent degradation

Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone

Hsp90 inhibitors block outgrowth of EBV-infected malignant cells in vitro and in vivo through an EBNA1-dependent mechanism.

Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance.

Purine-scaffold Hsp90 inhibitors.

The plasmid replicon of Epstein-Barr virus: mechanistic insights into efficient, licensed, extrachromosomal replication in human cells.

Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition.

Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.

Targeting Hsp90: small-molecule inhibitors and their clinical development.

A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors.

P304

1665-1666

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/CC.9.9.11594

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43201871

http://www.w3.org/2001/XMLSchema#string

P698

20404505

http://www.w3.org/2001/XMLSchema#string

P932

2879875

http://www.w3.org/2001/XMLSchema#string